Ken Miller
AstraZeneca
Dr. Ken Miller is currently an associate director within the commercial biologics operations organization at AstraZeneca. He has 16 years of experience in the biopharmaceutical industry, including 12 years as an analytical development scientist and CMC analytical lead at MedImmune. In his current role with AstraZeneca, he provides overall scientific and strategic leadership for the Bioassay, Impurities and Critical Reagents group within Global Technical Operations. He is responsible for the commercial lifecycle management of potency and process-related impurity methods and the management of logistics for critical reagents used in commercial batch release and stability testing. He earned a Ph.D. in Biological Sciences from Carnegie Mellon University and a Bachelor of Science degree in Biochemistry from Case Western Reserve University.